中國國民黨文傳會主委王育敏、副主委王鴻薇、黃子哲今(3)日召開「換位置換腦袋？蔡英文陳時中疫苗立場自打臉！」記者會，質疑蔡英文總統與陳時中部長對於疫苗政策的立場反覆、標準不一，被揭露後的自圓其說更是漏洞百出，人民如何還能信任蔡政府有能力提供安全、有效的疫苗？國民黨呼籲蔡政府應該盡速「排除意識型態的障礙」與民間團體合作採購疫苗，才是防範疫情持續擴散的根本解決之道。
國民黨表示，疫情嚴峻之際，蔡政府採購國際疫苗卻進度緩慢，與蔡英文總統2009年任民進黨主席、台灣爆發H1N1新型流感疫情之際，要求馬英九政府，「排除採購法的障礙，盡速向國際市場收購克流感藥物，以增加台灣克流感安全存量」的立場相違背，遭各界批評蔡英文昨是今非，總統府雖立即提出五點回應，但說法卻讓人民的疑問更深。
國民黨強調，疫苗是抑制疫情擴散的根本解決之道。2009年的蔡主席立場就是優先儘快地收購國際疫苗，對於國產疫苗則要求政府不應扮演推銷員的角色。但對照現今面對新冠肺炎疫情，已位居總統大位的蔡英文卻有髮夾彎式的大轉變，採購國際疫苗只是「盡量」，當前人民生命受到疫情的嚴重威脅，蔡英文當年展現的急迫性卻消失了，這難道不是雙重標準、立場不一嗎？
不僅國家元首換了位置就換了腦袋，國民黨表示，疫情指揮中心指揮官陳時中面對民間各界有意協助採購國際疫苗，卻頻給「軟釘子」，指稱「中央政府與原廠簽約採購」、「中央政府統籌分配執行」才能對疫苗的安全性、有效性負責；但陳時中難道忘了台塑集團的慈善基金會從他擔任衛生署副署長期間開始，即長期採購肺炎鏈球菌疫苗捐贈政府相關部門。國民黨表示，陳時中的堅持根本站不住腳，台灣急需疫苗的當下，身為指揮官聽不進社會的建言，處處為有意協助者設下門檻與障礙；英國金融時報（FT）最新評論即指出，擊潰台灣防疫防線的兩大問題之一就是「陳時中領導抗疫紀錄輝煌，聲望如日中天，使其他公衛專家不敢『逆時中』，也阻撓地方官員因應疫情時主動出擊」。國民黨要求，陳時中應該走下神壇，傾聽社會各界專業建議，疫苗政策上，扮演「協助者」的角色，而非「專制者」。
此外，駐德代表謝志偉、民進黨立委趙天麟等批評藝人張小燕「給我疫苗」的呼籲是「刁難防疫工作」、「為台灣製造仇恨」，國民黨質疑，難道當年蔡主席要求馬政府盡速向國際市場收購疫苗也是「刁難防疫工作」、「為台灣製造仇恨」嗎？民進黨的雙重標準從上到下皆是如此，難道批評平民百姓最基本的訴求就能轉移蔡政府無法提供充足疫苗讓人民安心的焦點嗎？請蔡總統制止蔡政府政務官員及黨籍民代對平民百姓的攻擊，專心防疫工作，才是執政團隊該有的作為。
「當說法不斷『校正』，信任就無法『回歸』」，國民黨表示，面對疫情嚴峻不止之際，蔡政府最大的問題在於主政者立場反覆、標準不一，導致疫苗政策無法有一貫性。蔡政府僅會用「滾動式調整」、「時空環境不同」等詞彙來掩飾錯誤決策的不斷修正，卻未給人民正確、完整、一貫性的資訊，難怪人民對蔡政府的疫苗政策失去信任、難以「回歸」！
Where President Tsai Stands Indeed Depends on Where She Sits. President Tsai and Health Minister Chen’s Stance on Vaccines Is Erratic at Best, Deceitful at Worst
“Where President Tsai Ing-wen (蔡英文) stands indeed depends on where she sits. President Tsai and Health Minister Chen’s stance on vaccines is erratic at best, deceitful at worst,” titled the press conference the Kuomintang (KMT) Cultural Communication Committee held today. (June 3) During the press conference, the KMT raises questions about the inconsistencies of Ms. Tsai and Mr. Chen’s stance on vaccine policy. With the standards for vaccine erratically shifting, how are Taiwan’s citizens supposed to trust the Tsai administration’s ability to provide safe, effective vaccines? The KMT calls upon the administration to preclude any ideology-formed barriers and work in tandem with civil groups to procure vaccines- which offers the best chance of stemming the spread of Covid-19.
The KMT notes that as the virus rages on, the progress of the administration’s efforts to procure vaccines has been stalling. “Eliminate the obstacles posed by the Government Procurement Act and purchase Tamiflu medications in the international market to increase our Tamiflu safety stocks,” clamored then DPP chairwoman Tsai Ing-wen when the swine flu pandemic, H1N1, struck Taiwan in 2009. Alas, her position at that time brutally contradicts the policy she enacts now as president. To fend off the public’s searing criticisms, the Presidential Office has set forth a five-point response. But it hardly tempers our citizens’ doubts- and indeed, it deepens them.
First, "the government will try to buy vaccines in the international market," claimed the presidential office. Ms. Tsai, in 2009, urged the government to acquire Tamiflu medications in the international market “as soon as possible.” Yet somehow, she claims her administration will “try” its best. The goal of increasing vaccine safety stockpiles is too important to rely on the flimsy word of “trying.”
Second, “the government concluded a contract with Covax last September, with AstraZeneca (AZ) in October, and with Moderna this February,” said the presidential office. President Tsai claims that she is keeping a close watch on the progress every day, but only about 860,000 doses- vastly lower than the 20 million doses promised in the contracts- were delivered to Taiwan this June. The presidential office must disclose the contract contents.
Third, the presidential office promised that to combat the virus, “the government will pull all levers of its power and set up a window for joint efforts by the government and private sector alike to procure more vaccines.” Does setting up a window mean vaccine procurements can go ahead without government approval? Or does the government still require that any contracts with foreign vaccine manufacturers be government-sanctioned? If so, how can we achieve the goal of purchasing vaccines "as soon as possible," as President Tsai insisted in 2009?
Fourth, indeed, domestic vaccines must unapologetically be a national strategic priority. But Ms. Tsai in 2009 asked that “the Health Ministry not side with manufacturers to advertently varnish the quality of Adimmune Corporation’s vaccines.” Why did Ms. Tsai at that time discount the contribution made by Adimmune Corporation’s vaccines? It seems Ms. Tsai has come to realize that domestic vaccines are a national strategic priority only after taking office.
Fifth, to clear the air on the accusation of insider trading, the president ordered an internal investigation. “There exist no problems of insider trading among relevant government personnel,” the presidential office declared. Faced with intensified suspicion from all quarters of society, why not refer the investigation to the prosecution? An internal inquiry serves only to whip up the public’s suspicion about a coverup. In endorsing the internal investigation, she ordered as president, Ms. Tsai perhaps wanted our prosecutors to steer clear of it.
The KMT stressed that vaccination offers the best hope of suppressing the virus. Ms. Tsai’s position in 2009 was to prioritize acquiring international vaccines as soon as possible while urging the government not to act as a salesman for domestic vaccines. At a time when our people’s lives are under threat of Covid-19, the sense of urgency Ms. Tsai had once demonstrated is now all but nonexistent. This smacks of a double standard.
The KMT avers that as the Covid-19 rampage persists, our leaders’ inconsistent stances and standards have led to a suite of incoherent vaccine policies. The Tsai administration only deploys phrases such as “rolling adjustment” and “adjustments to the change of time and environment” to gloss over the constant correction of wrong decisions. Meantime, it continues to fail to communicate correct, complete, and consistent information to the people. Little wonder Taiwan’s citizens lose trust in the Tsai administration’s vaccine policy.
（This is an abridged version of an official KMT Chinese language press release）
